DNA methylation is an important epigenetic modification. Evaluating the status of DNA methylation could be useful for diagnosis
prognostic evaluation and predicting the risk of cancer. Thyroid cancer is the most prevalent endocrine malignancy in humans. Growing evidence shows that epigenetic abnormalities participate with genetic alterations in carcinogenesis of thyroid cancer. This article reviewed the recent research progress of DNA methylation in thyroid cancer.
Interpretation of the 2025 American Thyroid Association Management Guidelines for Adult Patients with Differentiated Thyroid Cancer: advances in surgical treatment of differentiated thyroid cancer
Survival and cause-of-death analysis of 55 thousand thyroid cancer cases in China from a large single institution hospital-based cancer registry database
Current status and prospect of diagnosis and treatment of bone metastasis of thyroid cancer
Research progress in epidemiology and risk factors of thyroid cancer
Exploring the role of methylation-driven gene IFFO1 in pancreatic adenocarcinoma diagnosis, prognosis and cellular functions
Related Author
Jugao FANG
Qian SHI
Qinghai JI
Jie SHEN
Wanlin LIU
Zezhou WANG
Sibo MU
Miao MO
Related Institution
Department of Otolaryngology-Head and Neck Surgery, Beijing Tongren Hospital, Capital Medical University
Department of Cancer Prevention, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University
Department of Head and Neck Surgery, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University
School of Public Health, Fudan University
Shanghai Engineering Research Center of Artificial Intelligence Technology for Tumor Diseases